IRIS

We evaluated efficacy and safety of sofosbuvir and daclatasvir±ribavirin in liver transplant recipients with severe recurrent hepatitis C.

Pellicelli, A., Montalbano, M., Lionetti, R., Durand, C., Ferenci, P., D'Offizi, G., et al. (2014). Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late. DIGESTIVE AND LIVER DISEASE, 46(10), 923-927 [10.1016/j.dld.2014.06.004].

Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late

ANGELICO, MARIO
2014-01-01

Abstract

We evaluated efficacy and safety of sofosbuvir and daclatasvir±ribavirin in liver transplant recipients with severe recurrent hepatitis C.
2014
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/12 - GASTROENTEROLOGIA
English
Cholestatic hepatitis; Cirrhosis; Daclatasvir; Direct antiviral agents; Disease recurrence; HCV; MELD; Sofosbuvir; Adult; Aged; Antiviral Agents; Compassionate Use Trials; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Recurrence; Severity of Illness Index; Treatment Outcome; Uridine Monophosphate; Liver Transplantation
Pellicelli, A., Montalbano, M., Lionetti, R., Durand, C., Ferenci, P., D'Offizi, G., et al. (2014). Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late. DIGESTIVE AND LIVER DISEASE, 46(10), 923-927 [10.1016/j.dld.2014.06.004].
Pellicelli, A; Montalbano, M; Lionetti, R; Durand, C; Ferenci, P; D'Offizi, G; Knop, V; Telese, A; Lenci, I; Andreoli, A; Zeuzem, S; Angelico, M...espandi
Articolo su rivista
01 - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Sofosbuvir plus daclatasvir.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 544.76 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
544.76 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/113999
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 90
  • ???jsp.display-item.citation.isi??? 89
social impact